Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1683034

registered interest
date	17/01/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve the (a) adoption and (b) spread of medical technologies across the NHS.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	10124
answer	answer is ministerial correction date of answer 22/01/2024 answer text <p>In February 2023, the Government published its first ever strategy for MedTech, outlining our priorities for improving the adoption and spread of safe, effective and innovative medical technologies across the National Health Service.</p><p>As part of this effort, we are implementing solutions to streamline the innovation adoption pathway. We are focusing on clarifying signals to industry on what innovation the NHS needs, reforming regulation, providing product assessments based on real world evidence, and improving procurement processes.</p><p>We recently launched the Innovative Devices Access Pathway pilot in September 2023. The pilot will test a pre-regulatory, access pathway for eight pilot technologies that meet a clinical unmet need in the NHS. This accelerated pathway will support the adoption of transformative technologies into the NHS and to patients.</p><p>The Government is investing £30 million in the Health Tech Adoption and Acceleration Fund. Funding has been disseminated to all 42 integrated care systems to invest in proven technology that will help cut waiting lists, speed up diagnosis and deliver new and improved ways to treat patients.</p><p>The Department has partnered with the National Institute for Health and Care Excellence to develop and pilot a process for evaluations that compare similar MedTech products in use across the NHS. These evaluations will improve NHS decision makers ability to identify which products offer value for money and are worth adopting more widely.</p><p>The Medicines and Healthcare products Regulatory Agency is updating the medical device regulatory framework. The new framework is designed to protect patient safety, support innovation within the United Kingdom’s life sciences sector and improve access to innovative medical devices.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 22/01/2024 11:35:47 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4124 label Biography information for Chi Onwurah

1669252

registered interest
date	10/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	1400
answer	answer is ministerial correction date of answer 20/11/2023 answer text <p>A key criterion is clear, meaningful metrics that directly align to the core priorities of the Strategy. We are working with system partners, industry and patient groups and other key stakeholders to develop meaningful metrics for each initiative and for the overall robust evaluation of the strategy.</p><p>Our previous answer, which you reference in your question, outlined the range of different initiatives we are progressing. Each initiative is at a different stage of progress and will work up individual, appropriate criteria with their key delivery partners. These will be reported to programme governance structures as they become available.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 20/11/2023 17:07:05 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4807 label Biography information for Mark Eastwood

1666862

registered interest
date	24/10/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answers of 16 October 2023 to Questions 200120, 200121, 200122 and 200123 on Medial Treatments: Innovation, which criteria within the MedTech Strategy Programme governance structures will be used to assess the range of initiatives.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	204055
answer	answer is ministerial correction date of answer 26/10/2023 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Prorogation.</p> answering member constituency Colchester answering member printed Will Quince question first answered 26/10/2023 08:59:38 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661404

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the adoption of innovative medical technologies by the NHS.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200121
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200122 200123 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661405

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to innovative medical technologies through the NHS.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200122
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200121 200123 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1661406

registered interest
date	18/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of innovative medical technologies on the (a) Life Sciences Vision and (b) MedTech Strategy.
tabling member constituency	Dewsbury
tabling member printed	Mark Eastwood
uin	200123
answer	answer is ministerial correction date of answer 16/10/2023 answer text <p>The Department’s inaugural Medical Technology (MedTech) Strategy was published on 3 February 2023, building on the broader Life Sciences Vision. We are committed to ensuring that the Department utilises innovative MedTech as implementation progresses.</p><p>The MedTech Strategy includes a range of initiatives aimed at streamlining the end-to-end innovation pathway, including procurement routes, to expedite patient access to MedTech and boost adoption within the National Health Service.</p><p>The Innovative Devices Access Pathway pilot was launched on 19 September 2023. This new pathway will provide multi-partner support for the rapid development of innovative technologies for adoption into the NHS to address unmet clinical needs. More information on the pilot is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap" target="_blank">https://www.gov.uk/government/publications/the-innovative-devices-access-pathway-idap</a></p><p>The National Institute for Health and Care Excellence will undertake new Multi-Technology Evaluations of technologies in use and at a later stage in their lifecycle. These evaluations will enable comparisons between similar products and support the NHS to make better informed decisions on the right product for the right price.</p><p>The Department is working closely with NHS Supply Chain and NHS England to develop a consistent methodology for value-based procurement (VBP). VBP aims to shift procurement decisions away from an emphasis on reducing product costs to working with industry to consider technologies that represent a reduction in total costs within the patient pathway. Timeframes are still being determined.</p><p>The Department will consult on updating processes on applications to Part IX of the Drug Tariff to support the adoption of innovation in primary and community care.</p><p>The NHS Innovation Service is providing innovators with the resources, tools and support they need to increase the chances of getting their product or idea adopted by the NHS. More information is available at the following link:</p><p><a href="https://innovation.nhs.uk/" target="_blank">https://innovation.nhs.uk/</a></p><p>We plan to assess the impact of these initiatives through the MedTech Strategy Programme governance structures.</p> answering member constituency Colchester answering member printed Will Quince grouped question UIN 200120 200121 200122 question first answered 16/10/2023 13:22:56 answering member 4423 label Biography information for Will Quince
tabling member	4807 label Biography information for Mark Eastwood

1643161

registered interest
date	08/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure that patients have access to the most innovative treatment options within their own Integrated Care Systems.
tabling member constituency	Knowsley
tabling member printed	Sir George Howarth
uin	188486
answer	answer is ministerial correction date of answer 15/06/2023 answer text <p>It is our priority to ensure that patients have access to the most innovative treatment options, wherever they live in the country. Integrated care systems (ICS) are responsible for meeting the health needs of their local population. Integrated care boards are responsible for developing a plan for meeting the health needs of the population, managing the National Health Service budget and arranging for the provision of health services in the ICS area.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 188487 question first answered 15/06/2023 16:39:06 answering member 4527 label Biography information for Helen Whately
tabling member	481 label Biography information for Sir George Howarth

1643162

registered interest
date	08/06/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure that patients are able to access the most innovative treatment options even if they are only available outside of their own Integrated Care Systems.
tabling member constituency	Knowsley
tabling member printed	Sir George Howarth
uin	188487
answer	answer is ministerial correction date of answer 15/06/2023 answer text <p>It is our priority to ensure that patients have access to the most innovative treatment options, wherever they live in the country. Integrated care systems (ICS) are responsible for meeting the health needs of their local population. Integrated care boards are responsible for developing a plan for meeting the health needs of the population, managing the National Health Service budget and arranging for the provision of health services in the ICS area.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 188486 question first answered 15/06/2023 16:39:06 answering member 4527 label Biography information for Helen Whately
tabling member	481 label Biography information for Sir George Howarth

1587125

registered interest
date	20/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the Major Conditions Strategy will include targets for the uptake of innovative treatments such as biologics in the context of chronic respiratory diseases.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	148584
answer	answer is ministerial correction date of answer 01/03/2023 answer text <p>The Strategy will cover treatment and prevention for chronic respiratory disease and the Department will continue to work closely with stakeholders, citizens and the National Health Service in the coming weeks to identify actions that will have the most impact. The Strategy will also apply a geographical lens to address regional disparities in health outcomes, supporting the levelling up mission to narrow the gap by 2030.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 148583 148586 question first answered 01/03/2023 14:11:30 answering member 4527 label Biography information for Helen Whately
tabling member	4131 label Biography information for Jim Shannon

1585252

registered interest
date	08/02/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Innovation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to help streamline processes for future medical innovations so they are available in similar timeframes to covid-19 treatments.
tabling member constituency	Cambridge
tabling member printed	Daniel Zeichner
uin	142723
answer	answer is ministerial correction date of answer 20/02/2023 answer text <p>The Government is committed to supporting timely patient access to promising and innovative new treatments. Our Life Science Vision published in 2021 set out our ambition to build on the scientific successes and ways of working from COVID-19 to tackle the biggest disease challenges.</p><p>The United Kingdom’s participation in Project Orbis and the creation of the Innovative Licensing and Access Pathway (ILAP) are already enabling the more rapid review and approval of promising new medicines. In addition, the National Institute for Health and Care Excellence is introducing a more proportionate approach to appraisals that will create more flexibility in its medicine evaluation processes and speed up access for patients.</p> answering member constituency Colchester answering member printed Will Quince question first answered 20/02/2023 10:20:37 answering member 4423 label Biography information for Will Quince
tabling member	4382 label Biography information for Daniel Zeichner